Anders Wold, President and CEO, Clinical Care Solutions, GE Healthcare

Anders Wold

President and CEO, Clinical Care Solutions, GE Healthcare

The GE Vscan is among several point-of-care ultrasound systems being used to triage and monitor COVID-19 patients. I

COVID-19 is creating a new generation of cardiac patients.  With heart disease already the leading cause of deaths globally, this epidemic within a pandemic — a crisis within a crisis — creates a cardiology conundrum.

In all my years involved in healthcare, this is the most massive medical mystery I’ve encountered. The way patients are triaged, diagnosed, treated and monitored will forever change because of COVID-19.  Perhaps nowhere has that been more evident than in the field of cardiology.

Still in its infancy, the virus has layers upon layers of complexities, which have resulted in sometimes contrary observations and evidence about the impact it has on the heart.

In the early days, using ECG and ultrasound, clinicians in China reported signs of myocarditis and heart disease associated with COVID-19 patients. That data helped explain the spike in out-of-hospital cardiac arrests in the hard-hit northern region of Italy where Professor Luigi Badano, director of the cardiovascular imaging unit at Istituto Auxologico Italiano, IRCCS, and professor of cardiology at the University of Milano-Bicocca, uses strain imaging on ultrasound to understand the function of the right ventricle in predicting the prognosis of those patients who will survive the virus.

Currently, the United States surpasses 5 million recorded COVID-19 cases and record numbers of hospitalizations. New studies reinforce the earlier evidence suggesting that COVID-19 patients may have long term heart damage, while another study published by the American Heart Association (AHA) indicates suspected damage to the heart may not be myocarditis, but rather a unique pattern of cell death in scattered individual heart muscle cells. 

These observational studies, albeit small, are eye-opening and underscore the need for more research with larger sample sizes that will help draw solid conclusions to guide effective therapies and treatments. But the practice of medicine takes time, which is in short supply.

Hospitals have worked diligently to reassure patients that it’s not only safe, but important to seek medical care during the pandemic.  But, out of fear of contagion, many patients delay care.  As a med tech company with more than 40 years of experience in cardiology, we anticipate this delay puts patients with pre-existing cardiac conditions at even a greater risk of long-term harm, and additional burden on cardiologists as they manage care with new constraints.  At the same time, technology is opening the door for patient care to exist beyond the walls of the hospital, to manage patients on site and provide their caregivers with up-to-date information on their well-being.

When it comes to treating COVID-19 patients, clinicians globally are already using our technologies such as ECG to perform rapid first line diagnostic tests to identify cardiac emergencies and improve triage, and AI enabled ultrasound like a handheld device for automated, fast and objective ejection fraction measurement and a point-of-care ultrasound system that, in seconds, automates critical information needed by ER and ICU doctors to determine if the heart is pumping enough blood through the primary arteries to the organs.  As we look to the future, we will bring new technologies and solutions to the market that improve efficiency, productivity and clinical outcomes to meet the demands of this new world.

While these are puzzling times, the medical field continues to practice patience and perseverance — even as a rapidly spreading virus creates urgency on several fronts.  What we don’t know now won’t stop us from figuring it out. Let’s fix what we can, learn as we go and continue forging ahead, wherever it may lead us.

Editor's note: Anders Wold is president and CEO, clinical care solutions, at GE Healthcare. He is celebrating 22 years at GE Healthcare and nearly four decades working in healthcare, with most of his focus in cardiovascular ultrasound.

 

POCUS for COVID-19 and Cardiology Related Content:

DiA Imaging Analysis Receives Grant to Accelerate Access Ultrasound AI in Fight Against COVID-19

VIDEO: CT and POCUS Emerge As Frontline Cardiac Imaging Modalities in COVID-19 Era  — Interview with ith Geoffrey Rose, M.D.

VIDEO: GE AI-Assisted Automatic Ejection Fraction for Point-of-Care Ultrasound

FDA Clears Philips Ultrasound Portfolio to Image COVID-19 Related Lung and Cardiac Complications

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)

VIDEO: Automated Cardiac Ejection Fraction for Point-of-care-ultrasound Using Artificial Intelligence

LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction

GE Highlights New Echocardiography Technologies at ASE 2020

Related Content

News | Cardiac Diagnostics

October 4, 2021 – Nanowear, a hospital-at-home and remote diagnostic platform that used proprietary wearable cloth ...

Home October 04, 2021
Home
News | Cardiac Diagnostics

September 28, 2021 — Biotricity Inc., a medical diagnostic and consumer healthcare technology company, has developed a ...

Home September 28, 2021
Home
News | Cardiac Diagnostics

July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation ...

Home July 29, 2021
Home
News | Cardiac Diagnostics

July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation ...

Home July 01, 2021
Home
News | Cardiac Diagnostics

March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potential ...

Home March 08, 2021
Home
News | Cardiac Diagnostics

March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management ...

Home March 03, 2021
Home
News | Cardiac Diagnostics

February 2, 2021 — A new study has found in the U.S. shows higher economic prosperity was associated with a small ...

Home February 02, 2021
Home
News | Cardiac Diagnostics

January 6, 2021 — Smoking traditional cigarettes in addition to using e-cigarettes results in harmful health effects ...

Home January 06, 2021
Home
News | Cardiac Diagnostics

October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc. using a superconducting quantum ...

Home October 06, 2020
Home
News | Cardiac Diagnostics

May 11, 2020 — The American Society for Preventive Cardiology (ASPC) is collaborating with Intervent International to ...

Home May 11, 2020
Home
Subscribe Now